Recent Regulatory Impacts on the Pain-Management Space
PharmExec.com Recent Regulatory Impacts on the Pain-Management Space March 12,
The NIH’s Role in New Drug Development
PharmExec.com The NIH’s Role in New Drug Development March 7,
Developing Non-Addictive Pain Medication
PharmExec.com Developing Non-Addictive Pain Medication March 5, 2025 Dr. Hernan
Podcast: Conversations Life Science Leaders Aren’t Having
Podcast: Conversations Life Science Leaders Aren’t Having “A Masterclass in
Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids Here to Stay
BioSpace Vertex’s Journavx Changes the Pain Treatment Landscape But Opioids
Healthcare Entrepreneurs Express Hope, Concern Over RFK Jr. Confirmation
The Wall Street Journal Healthcare Entrepreneurs Express Hope, Concern Over
FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era in Pain Treatment
BioSpace FDA Approval of Vertex’s Non-Opioid Journavx Signals New Era
Progress, Potential, and Possibilities with Ira Pastor
Progress, Potential, and Possibilities with Ira Pastor Feb 3, 2025
The Fentanyl Crisis and the Lack of Pain Management Alternatives
Doximity Op-Med The Fentanyl Crisis and the Lack of Pain
Opioid Alternatives Face an Uphill Battle Against Insurers and Doctors
Bloomberg Businessweek Opioid Alternatives Face an Uphill Battle Against Insurers